NICE Appraisals
Ask
Browse
Corpus
About
TA939
· STA
pembrolizumab plus chemotherapy with or without bevacizumab for persistent, recurrent or metastatic cervical cancer
May 2023
Source documents
Final Appraisal Document
Appraisal Consultation Document
Committee Papers
Scope
Scope
Scope Consultation Comments
Special considerations
Cancer Drugs Fund eligible
Equality issues raised